These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 17101503)

  • 1. Pemphigus: a treatment update.
    Dick SE; Werth VP
    Autoimmunity; 2006 Nov; 39(7):591-9. PubMed ID: 17101503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment options for pemphigus foliaceus.
    Fernando SL; Broadfoot AJ
    G Ital Dermatol Venereol; 2009 Aug; 144(4):363-77. PubMed ID: 19755942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in pemphigus therapy.
    Prajapati V; Mydlarski PR
    Skin Therapy Lett; 2008 Apr; 13(3):4-7. PubMed ID: 18506357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pemphigus vulgaris and pemphigus foliaceus: similar prognosis?
    Zaraa I; Mokni M; Hsairi M; Boubaker S; Sellami M; Zitouni M; Makni S; Dhahri AB
    Int J Dermatol; 2007 Sep; 46(9):923-6. PubMed ID: 17822493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of sensitivity and specificity of enzyme-linked immunosorbent assay (ELISA) for detecting antidesmoglein 1 and 3 in Thai patients with pemphigus vulgaris and foliaceus.
    Kulkollakarn S; Wattanakrai P; Vachiramon V; Chalidapongse P
    J Med Assoc Thai; 2008 Nov; 91(11):1663-8. PubMed ID: 19127786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data.
    Gürcan HM; Ahmed AR
    Am J Clin Dermatol; 2009; 10(6):383-96. PubMed ID: 19824739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pemphigus vulgaris and paraneoplastic pemphigus.
    Edgin WA; Pratt TC; Grimwood RE
    Oral Maxillofac Surg Clin North Am; 2008 Nov; 20(4):577-84. PubMed ID: 18940624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pemphigus vulgaris: a case-based update.
    Ben Lagha N; Poulesquen V; Roujeau JC; Alantar A; Maman L
    J Can Dent Assoc; 2005 Oct; 71(9):667-72. PubMed ID: 16271165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature.
    Cianchini G; Corona R; Frezzolini A; Ruffelli M; Didona B; Puddu P
    Arch Dermatol; 2007 Aug; 143(8):1033-8. PubMed ID: 17709662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases.
    Segura S; Iranzo P; Martínez-de Pablo I; Mascaró JM; Alsina M; Herrero J; Herrero C
    J Am Acad Dermatol; 2007 Jun; 56(6):960-7. PubMed ID: 17368865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pemphigus foliaceus with circinated plaques and neutrophil pustules.
    Méndez-Flores S; Avalos-Diaz E; Dominguez-Cherit J; Saeb-Lima M; Esquivel-Pedraza L
    J Cutan Pathol; 2016 Nov; 43(11):1062-1066. PubMed ID: 27514363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New and innovative interventions in the management of pemphigus.
    Frydman AS; Fairley JA
    G Ital Dermatol Venereol; 2011 Jun; 146(3):211-24. PubMed ID: 21566551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune bullous dermatoses: a review.
    Patrício P; Ferreira C; Gomes MM; Filipe P
    Ann N Y Acad Sci; 2009 Sep; 1173():203-10. PubMed ID: 19758152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blistering mucocutaneous diseases of the oral mucosa--a review: part 2. Pemphigus vulgaris.
    Darling MR; Daley T
    J Can Dent Assoc; 2006 Feb; 72(1):63-6. PubMed ID: 16480607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An 'n-of-1' placebo-controlled crossover trial of intravenous immunoglobulin as adjuvant therapy in refractory pemphigus vulgaris.
    Arnold DF; Burton J; Shine B; Wojnarowska F; Misbah SA
    Br J Dermatol; 2009 May; 160(5):1098-102. PubMed ID: 19222460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of pemphigus vulgaris.
    Kavusi S; Daneshpazhooh M; Farahani F; Abedini R; Lajevardi V; Chams-Davatchi C
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):580-4. PubMed ID: 18194237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transition from pemphigus foliaceus to bullous pemphigoid: intermolecular B-cell epitope spreading without IgG subclass shifting.
    Recke A; Rose C; Schmidt E; Bröcker EB; Zillikens D; Sitaru C
    J Am Acad Dermatol; 2009 Aug; 61(2):333-6. PubMed ID: 19615544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral mucosal disease: pemphigus.
    Scully C; Mignogna M
    Br J Oral Maxillofac Surg; 2008 Jun; 46(4):272-7. PubMed ID: 17870218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pemphigus vulgaris: a therapeutic option for disease control.
    da Silva AV; Valones MA; Guimaraes RP; de Castro JF; Carvalho Ade A
    Gen Dent; 2008; 56(7):700-3. PubMed ID: 19014030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 6-year treatment experience for pemphigus: retrospective study of 69 Chinese patients.
    Bai YX; Zhang LM; Xiao T; Chen HD
    Dermatol Ther; 2016; 29(2):84-7. PubMed ID: 27060935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.